Parenteral Drug (India) share news and announcements
BSE: 524689Pharmaceuticals & Biotechnology
Trading suspended since 3 Feb 2025
Last traded ₹2.90 on 21 Aug 2023
Parenteral Drug (India) share news and announcements
782 announcements, routine notices left out, newest first. Page 15 of 16.
Jan 2013
22 Jan · Board meeting
To consider inter-alia un-audited financial results of the Company for the Third quarter ended on December 31, 2012.
Nov 2012
27 Nov · Business
Board of Directors of the Company at its meeting held on November 09, 2012, has issued and allotted 70,37,898 0% Redeemable Preference Shares of Rs.10/- each at a premium of Rs. 51.40 per share out of which 52,11,000 preference shares are fully paid up and 18,26,898 preference shares shall be partly paid up which shall be made fully paid up within a period of 18 months from the date of allotment.27 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 09, 2012, has issued and allotted 70,37,898 0% Redeemable Preference ....12 Nov · Updates
Corporate Debt Restructuring Cell, Mumbai vide letter dated November 08, 2012 has conveyed that the final restructuring package for the company has been approved by CDR EG. Necessary steps pursuant to the approval are being taken by the lenders.12 Nov · Approval of CDR proposal for the Company
Corporate Debt Restructuring Cell, Mumbai vide letter dated November 08, 2012 has conveyed that the final restructuring package for ....12 Nov · Limited Review for Sep 30, 2012
Oct 2012
31 Oct · Board meeting
To consider inter-alia un-audited financial results of the Company for the second quarter ended on September 30, 2012.
Sep 2012
4 Sep · Corporate action
Register of Members & Share Transfer Books of the Company will remain closed from September 26, 2012 to September 29, 2012 (both days ....3 Sep · Corporate action
Register of Members and Share Transfer Books of the Company shall remain closed from September 26, 2012 to September 29, 2012 for the purpose of Annual General Meeting.
Aug 2012
23 Aug · Limited Review for June 30, 2012
6 Aug · Board meeting
To consider, inter-alia un-audited financial results of the Company for the First quarter ended on June 30, 2012.
Jun 2012
15 Jun · Updates
Vide its letter dated June 11, 2012 that "the Lead Banker of the Company State Bank of India and other consortium bankers have, after due consideration, forwarded the Corporate Debt Restructuring proposal of the Company to the CDR cell for consideration."15 Jun · CDR Proposal of the Company
Lead Banker of the Company State Bank of India and other consortium bankers have, after due consideration, forwarded the Corporate Debt ....
May 2012
21 May · Board meeting
To consider inter-alia approval of the Audited Annual Accounts of the Company for the financial year ended March 31, 2012.14 May · Results
Company has decided to publish Audited Financial Results for the year ended/quarter ended March, 2012 instead of Un-audited Financial Results for the quarter ended March 31, 2012. The Audited Financial Results shall be published within 60 days from end of last quarter (i.e. on or before May 30, 2012).14 May · Results
Company has decided to publish Audited Financial Results for the year ended/quarter ended March 2012 instead of Un-audited Financial ....
Feb 2012
Jan 2012
31 Jan · Board meeting
To consider inter-alia un-audited financial results of the Company for the third quarter ended on December 31, 2011.
Dec 2011
8 Dec · Legal
With reference to the earlier announcement dated December 08, 2011 regarding clarification on Increase in Price, Parenteral Drugs India Ltd has now informed BSE that, the same clarification ....8 Dec · Legal
Price movement : Significant price movement has been observed in Parenteral Drugs (India) Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Parenteral Drugs (India) Limited has vide its letter inter-alia stated, "We would like to submit that with regard to the perfomance of the Company and internal price sensitive factors (which do not include any change in Govt. policies), the same are being submitted to you from time to time as per the requirement of the Listing Agreement. Further, there is no internal price sensitive information which has not been communicated to the Exchange (s) by the Company."8 Dec · Legal
With reference to "Increase in Price", Parenteral Drugs India Ltd has clarified to BSE that the with regard to the performance of the Company and internal price sensitive factors (which ....
Nov 2011
3 Nov · Board meeting
To consider inter-alia un-audited financial results of the Company for the second quarter ended on September 30, 2011.
Oct 2011
Sep 2011
13 Sep · Meeting
Annual General Meeting of the Company will be held on September 30, 2011.
Aug 2011
25 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 27, 2011 to September 30, 2011 (both days ....23 Aug · Corporate action
Register of Members and Share Transfer Books of the Company shall remain closed from September 27, 2011 to September 30, 2011 for the purpose of Annual General Meeting.16 Aug · Board meeting
To consider inter-alia approval of the audited annual accounts of the Company for the financial year ended March 31, 2011.
Jul 2011
11 Jul · Board meeting
To consider inter-alia un-audited financial results of the Company for the first quarter ended on June 30, 2011.
May 2011